A new cell-transplant procedure is showing early signs of success in helping people with Type 1 diabetes live without insulin ...

A new approach using stem cells to rebuild insulin-producing beta cells may help people with diabetes restore natural insulin ...

Findings represent a detailed resource for future research that could lead to the development of new biomarkers and targeted therapeutics for T1D.

A specially devised hybrid treatment has shown tremendous potential for treating type 1 diabetes in mice, scoring full marks at preventing the condition in prediabetic animals and at reversing the ...

In early-stage type 2 diabetes, the number of beta cells was not much lower than normal. This means that the disease does not ...

New imaging method lets scientists study insulin-producing islet cells in awake mice, revealing real-time blood sugar ...

Researchers at Karolinska Institutet have established a novel transplantation site for islets of Langerhans that enables long ...

Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced preliminary results from an investigator-initiated trial conducted at the University of Chicago Medicine’s Transplant Institute ...

A combination blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely ...

A combination of blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely ...

The autoimmune disorder destroys the body’s ability to produce insulin. Some patients in experimental trials have gotten it ...